New Treatment for Nasal Polyps
Are recurrent nasal polyps becoming an issue?
The occurrence of nasal polyps among the population in the U.S. ranges from 1-4%, with approximately 200,000 new cases of nasal polyps reported every year. The incidence rate is more common among men than women, and increases over the age of 30.
Nasal polyps are inflammatory noncancerous growths along the lining of the nasal passages that could occur in patients who are suffering from chronic sinusitis. They symptoms of chronic sinusitis may include nasal discharge, congestion, facial pain, and a loss of sense of smell. Polyps tend to reoccur, and many patients redevelop polyps even after undergoing previous ethmoid sinus surgery. There are several options for treating polyps both medically and surgically, and we now offer an additional treatment option.
Scotch Institute of Ear Nose & Throat, located in Wesley Chapel, FL, is among one of the first offices to offer the SINUVA™ Sinus Implant, a new in-office treatment option for recurring nasal polyps. This new technology recently approved by the FDA offers a new treatment in nasal polyps in adults who have had previous ethmoid sinus surgery (ESS) and offers a sustained relief for managing this chronic condition.
SINUVA Sinus Implant is placed by our physician in the office setting. SINUVA expands in the sinus cavity, delivering a corticosteroid (mometasone furoate) directly to the sinus for up to 90 days. SINUVA softens over time and can be removed at 90 days or earlier at the physician’s discretion.
To learn more about SINUVA, contact our office at 813-994-8900 or visit SINUVA.com.